Zonagen (zona) - good buy? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill Wexler who wrote (2244)	2/7/1998 8:42:00 PM
From: Dauntless	Read Replies (1) of 7041

Your frothing at the mouth has apparently blurred your vision. You wrote: <<It is extremely interesting to note that TXB's capitalization structure has amazing parallels to Zonagen. Just like Zonagen's fortuitous deal with Scering-plough, TXB also has a licensing deal with a reputable firm - SmithKline, who also happens to be an early investor.>> Two questions - which I know you won't answer.. 1- Is there something unusual about marketing deals in the pharmaceutical industry? Why is this a harbinger of something bad?? 2- SmithKline's "investment" in TXB was part of the marketing deal in late 1997 - why do you refer to them as an early investor?? You should read your own links sometimes - or doesn't Asensio allow you to do that?? I don't think people invest in companies based on the quality of their web page - or do you? Zonagen's reached a market cap of over $200 million without a "well-organized and Professional-looking web page. I am going to enjoy watching you squeal in just a "short" time. You must know what's coming soon?????

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next